ReviewInterventional cardiology clinics2019
State-of-the-Art Atrial Septal Defect Closure Devices for Congenital Heart.
Review in Interventional cardiology clinics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 30 citations in OpenAlex.
- Complications after percutaneous device closure of atrial septal defects in children: Prevalence, outcomes and associated factors.International journal of cardiology. Congenital heart disease · 2026Article
- Life-Threatening Aorto-Atrial Erosion Following Transcatheter Ostium Secundum Atrial Septal Defect Closure: A Case-Based Review.Life (Basel, Switzerland) · 2026Review
- Interatrial Conduction Block in Pediatric Patients with Ostium Secundum Atrial Septal Defect.Journal of clinical medicine · 2026Article
- Efficacy and Safety of Percutaneous ASD Closure in Adults: Comparative Outcomes of Occluder Devices in a Single-Center Cohort.Journal of clinical medicine · 2025Article
- Upsizing of GORE® Cardioform ASD Occluder for Atrial Septal Defect With Atrial Septal Aneurysm.Cureus · 2024Article
- Article
- Mid-Term Electrical Remodeling after Percutaneous Atrial Septal Defect Closure with GCO Device in a Pediatric Population.Journal of clinical medicine · 2023Article
- Echocardiography Imaging of the Right Ventricle: Focus on Three-Dimensional Echocardiography.Diagnostics (Basel, Switzerland) · 2023Review
- Transseptal Puncture Guided by Three-Dimensional Electroanatomical Mapping: Early Experience Using a Simplified Approach in Adults with Congenital Heart Disease.Journal of clinical medicine · 2023Article
- Assessment of Nit-Occlud atrial septal defect occluder device healing process using micro-computed tomography imaging.PloS one · 2023Article
- Emerging Concepts on Infection of Novel Cardiac Implantable Devices.Reviews in cardiovascular medicine · 2022Review
- Transcatheter Device Therapy and the Integration of Advanced Imaging in Congenital Heart Disease.Children (Basel, Switzerland) · 2022Review
- Patent foramen ovale occlusion with the Cocoon PFO Occluder. The PROS-IT collaborative project.Frontiers in cardiovascular medicine · 2022Article
- Transcatheter Closure of Atrial Septal Defect with Carag Bioresorbable Septal Occluder™: First-in-Child Experience with 12-MonthFollow-Up.Journal of interventional cardiology · 2022Article
- Proximalized Total Arch Replacement Can Be Safely Performed by Trainee.The Thoracic and cardiovascular surgeon · 2021Article
- Key Regulatory Differentially Expressed Genes in the Blood of Atrial Septal Defect Children Treated With Occlusion Devices.Frontiers in genetics · 2021Article
- Patent foramen ovale in children: Unique pediatric challenges and lessons learned from adult literature.Annals of pediatric cardiologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
This article describes current devices and indications for transcatheter device closure of atrial septal defect (TC-ASD) and patent foramen ovale in children and young adults. TC-ASD has a proven record of efficacy and safety, but device erosion raises questions about the relative safety of TC-ASD versus operative open heart surgical ASD closure. New devices for ASD closure with properties to reduce risk of erosion are being developed. Recent studies demonstrating superiority of patent foramen ovale device closure over medical therapy for cryptogenic stroke may lead to changes in practice for structural/interventional cardiologists. Care should be taken in extrapolating data to children and younger adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.